New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices

— The EluPro BioEnvelope findings demonstrate the bioactive properties and superior healing response compared to synthetic materials for cardiac implantable electronic devices (CIEDs) —

Read more at globenewswire.com